Drug recall: Acetylcysteine Ophthalmic 10% Solution, 5 mL per dropper bottle (10ML). Redline Specialty Pharmacy, 2415 Osborne Drive E
FDA enforcement event 85081 is a drug recall by Redline Pharmacy Solutions of Hastings, NE, initiated 24 Feb 2020 and classified Class II, with 6 product records.
FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 64% of the 342 drug enforcement events initiated in 2020 carry the same class.
Status: Terminated, terminated 31 Mar 2022. Initiation: voluntary: firm initiated. This is the only enforcement event on this register for Redline Pharmacy Solutions.
Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.
Recalling firm
Redline Pharmacy Solutions, Hastings, NE.
Reason for recall
"Lack Of Processing Controls"
Distribution
"Sold to patients in Nebraska"
Product records
| Recall number | Product | Quantity | Class | Status | Report date |
|---|---|---|---|---|---|
| D-1006-2020 | Acetylcysteine Ophthalmic 10% Solution, 5 mL per dropper bottle (10ML). Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901 | 2x5 ml bottles | Class II | Terminated | 18 Mar 2020 |
| D-1007-2020 | Morphine Sulfate, 20 mg/mL intrathecal, 20 mL per syringe. Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901 | 1 20 ml syringe | Class II | Terminated | 18 Mar 2020 |
| D-1008-2020 | Daptomycin, 500MG in 0.9% NACL 100ML Injectable Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901 | 16 doses | Class II | Terminated | 18 Mar 2020 |
| D-1009-2020 | Ertapenem in 100ML 0.9% NACL 1GM Injectable, Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901 | 8 doses | Class II | Terminated | 18 Mar 2020 |
| D-1010-2020 | Vancomycin 900MG in 100ML 0.9% NACL Injectable, Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901 | 3 doses | Class II | Terminated | 18 Mar 2020 |
| D-1011-2020 | Morphine Sulfate (MITIGO), 5 mg/mL intrathecal, 40 mL per syringe. Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901 | 1 40 ml syringe | Class II | Terminated | 18 Mar 2020 |
Context
Questions and answers
Why was this drug recalled?
FDA's record gives the reason for recall as: "Lack Of Processing Controls"
What does Class II mean?
FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Where was the product distributed?
FDA's distribution pattern field reads: "Sold to patients in Nebraska"
Is the recall still ongoing?
FDA lists the status as Terminated; the termination date is 31 Mar 2022. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.
Where does this data come from?
openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.
Provenance
Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.